Cytokinetics, Incorporated (CYTK)
NASDAQ: CYTK · Real-Time Price · USD
55.96
-0.23 (-0.41%)
Nov 13, 2024, 4:00 PM EST - Market closed
Cytokinetics Market Cap
Cytokinetics has a market cap or net worth of $6.60 billion as of November 13, 2024. Its market cap has increased by 114.38% in one year.
Market Cap
6.60B
Enterprise Value
6.41B
1-Year Change
114.38%
Ranking
Category
Stock Price
$55.96
Market Cap Chart
Since April 30, 2004, Cytokinetics's market cap has increased from $419.30M to $6.60B, an increase of 1,475.02%. That is a compound annual growth rate of 14.36%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Nov 12, 2024 | 6.63B | -19.00% |
| Dec 29, 2023 | 8.19B | 88.80% |
| Dec 30, 2022 | 4.34B | 13.41% |
| Dec 31, 2021 | 3.82B | 159.95% |
| Dec 31, 2020 | 1.47B | 134.61% |
| Dec 31, 2019 | 626.90M | 81.29% |
| Dec 31, 2018 | 345.80M | -21.27% |
| Dec 29, 2017 | 439.20M | -10.79% |
| Dec 30, 2016 | 492.30M | 21.17% |
| Dec 31, 2015 | 406.30M | 38.57% |
| Dec 31, 2014 | 293.20M | 52.87% |
| Dec 31, 2013 | 191.80M | 104.04% |
| Dec 31, 2012 | 94.00M | 35.45% |
| Dec 30, 2011 | 69.40M | -49.60% |
| Dec 31, 2010 | 137.70M | -22.34% |
| Dec 31, 2009 | 177.30M | 25.83% |
| Dec 31, 2008 | 140.90M | -39.40% |
| Dec 31, 2007 | 232.50M | -17.84% |
| Dec 29, 2006 | 283.00M | 51.01% |
| Dec 30, 2005 | 187.40M | -35.49% |
| Dec 31, 2004 | 290.50M | -30.72% |
View and export this data all the way back to 2004.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Jazz Pharmaceuticals | 7.47B |
| Ascendis Pharma | 7.43B |
| Legend Biotech | 7.38B |
| Bausch + Lomb | 7.04B |
| Elanco Animal Health | 6.96B |
| Nuvalent | 6.73B |
| Blueprint Medicines | 6.41B |
| Corcept Therapeutics | 6.24B |